COMMUNIQUÉS West-GlobeNewswire

Oncology Venture prolongs subscription period

30/04/2019 - 14:30

Press release Hørsholm, Denmark April 30, 2019 – Oncology Venture A/S has decided to extent the subscription period in current rights issue. Rights issue In light of the clinical news published in press release today [...]

Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program

30/04/2019 - 14:30

OCALA, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc., an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, [...]

Allogene Therapeutics to Report First Quarter 2019 Financial Results on May 7, 2019

30/04/2019 - 14:30

Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company [...]

Latest Wound Care Research from Organogenesis Highlighted at SAWC Spring 2019

30/04/2019 - 14:30

CANTON, Mass. and SAN ANTONIO, April 30, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of [...]

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

30/04/2019 - 14:30

Mavacamten is Being Developed to Treat the Most Common Inherited Form of Heart Disease, Hypertrophic Cardiomyopathy, for Which No Targeted Medical Therapies Exist Twelve-Week Treatment with Mavacamten Demonstrated [...]

Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate Update

30/04/2019 - 14:30

NOVATO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]

Auris Medical Announces Reverse Stock Split

30/04/2019 - 14:30

Hamilton, Bermuda, April 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology [...]

AMAG Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 at 8:00 a.m. ET

30/04/2019 - 14:05

WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019 before the U.S. [...]

AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

30/04/2019 - 14:00

WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase [...]

Dova Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 7, 2019

30/04/2019 - 14:00

DURHAM, N.C., April 30, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Tuesday, May 7, 2019 at 9:00 a.m. ET to discuss first quarter 2019 financial results and recent [...]

OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019

30/04/2019 - 14:00

MIAMI, April 30, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended March 31, 2019, as well as provide guidance on expected revenues [...]

Imprivata Introduces IAM Cloud Platform for Healthcare Supported by Microsoft

30/04/2019 - 14:00

First phase of collaboration extends enterprise-wide single sign-on to the cloud LEXINGTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that it will unlock [...]

CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8

30/04/2019 - 14:00

NEWARK, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Tetra Natural Health Announces The Arrival of 20 containers of Hemp Energy Drink in Canada

30/04/2019 - 14:00

1.7 million cans to be distributed in Montreal, Toronto and Vancouver OTTAWA, April 30, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), announces the [...]

Tetra Santé Naturelle annonce l'arrivée de 20 conteneurs de Hemp Energy Drink au Canada

30/04/2019 - 14:00

1,7 millions de canettes réparties entre Montréal, Toronto et Vancouver OTTAWA, 30 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce l’ [...]

Genocea Provides Corporate Update, Including First-Quarter 2019 Financial Results

30/04/2019 - 14:00

Company anticipates presenting first GEN-009 immunogenicity data at ASCO 2019 Conference call today at 9:00 am ET CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a [...]

Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting

30/04/2019 - 14:00

NEW YORK and CLEVELAND, April 30, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today will report new preclinical data demonstrating that ABO-401, [...]

HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases

30/04/2019 - 14:00

Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz., April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company [...]

BioVie Achieves Primary Objectives in Phase 2a Clinical Trial of BIV201 in Refractory Ascites

30/04/2019 - 14:00

LOS ANGELES, April 30, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, today announced top-line results for [...]